Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 4, Number 4—December 1998

Synopsis

Rotavirus

Umesh D. ParasharComments to Author , Joseph S. Bresee, Jon R. Gentsch, and Roger I. Glass
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 7

Percentage of children with adverse reactions during 5 days of surveillance following each of three doses of tetravalent rhesus-rotavirus vaccine (RRV-TV) or placebo. A) percentage with fever (as measured by axillary temperatures).*On day 4, 2.2% of RRV-TV recipients vs. 0.2% of placebo recipients became febrile (p = 0.02). B) percentage with diarrhea. C) percentage with vomiting. Adapted from (43).

Figure 7. Percentage of children with adverse reactions during 5 days of surveillance following each of three doses of tetravalent rhesus-rotavirus vaccine (RRV-TV) or placebo. A) percentage with fever (as measured by axillary temperatures).*On day 4, 2.2% of RRV-TV recipients vs. 0.2% of placebo recipients became febrile (p = 0.02). B) percentage with diarrhea. C) percentage with vomiting. Adapted from (43).

Main Article

TOP